Obesity Trial, Recruiting NCT07216820 Sponsor: University of North Carolina, Chapel Hill Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07216820
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People with a body mass index (BMI) of 35 or higher, measured at a pre-surgery clinic visit
  • People scheduled for a planned (non-emergency) shoulder surgery on one side — such as shoulder scope, shoulder replacement, rotator cuff repair, or reverse shoulder replacement — performed under general anaesthesia at UNC Hospitals
  • People whose anaesthesia plan includes a single nerve-blocking injection near the shoulder (called a brachial plexus block) to help manage pain after surgery
  • People who are able to complete a breathing strength test at the screening visit, producing two consistent efforts
  • People who are able to read or understand English and sign a consent form

Who may not be able to join:

  • People having emergency or trauma-related shoulder surgery, or whose surgery is converted to an open (non-keyhole) procedure
  • People who test positive for pregnancy on the day of surgery
  • People who are currently incarcerated or who are legally unable to give their own consent
  • People with severe lung disease — including advanced COPD (stage 3 or 4), certain restrictive lung conditions unrelated to weight, significant breathlessness at rest or with minimal activity, or those who use home oxygen
  • People with serious heart conditions — including severe heart valve disease, advanced heart failure (Class III or IV), or blocked heart arteries causing chest pain
  • People with nerve or muscle diseases that affect their breathing muscles (such as ALS or myasthenia gravis), or known paralysis of the diaphragm (the main breathing muscle)
  • People with blood clotting problems (such as low platelets or an elevated clotting measure called INR), or a skin infection at the site where the nerve block would be given
  • People with significant anaemia or certain inherited blood/haemoglobin conditions
  • People with a known allergy to bupivacaine (a local anaesthetic), dexamethasone (a steroid), or ultrasound gel
  • People using high-dose opioid pain medications (more than 100 mg oral morphine equivalent per day) in the three months before surgery
  • People who have previously participated in this trial, or who are already enrolled in another interventional research study that could affect the results
  • People who the investigator determines are unlikely to be able to complete the post-surgery assessments — for example, due to significant cognitive impairment or a planned transfer to another facility

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Monika Nanda, University of North Carollina at Chapel Hill

Phone: 919-966-5136

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 January 2026
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of Early Postoperative Respiratory Compromise; Effect Modification by Preoperative Maximum Inspiratory Pressure (MIP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov